Drug Shortage Report for OSTO-D2
Report ID | 55938 |
Drug Identification Number | 02301911 |
Brand name | OSTO-D2 |
Common or Proper name | OSTO-D2 |
Company Name | PALADIN LABS INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VITAMIN D2 |
Strength(s) | 50000UNIT |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 capsules |
ATC code | A11CC |
ATC description | VIT A AND D, INCL COMBINATIONS OF THE TWO |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-04 |
Actual start date | 2018-07-04 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-06-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-07-16 | French | Compare |
v1 | 2018-07-16 | English | Compare |
Showing 1 to 2 of 2